IGF1 and myocardial infarction: IGF1 has been extensively studied to treat the heart after MI as it counteracts adverse cardiac remodeling working directly on cardiomyocytes and inflammatory cells; reduced apoptosis33,34, cardioprotective effects against oxidative stress-dependent cell death35 and modulation of the inflammatory response8 at the infarcted area are possible underlying mechanisms.